1. Home
  2. PTCT vs SMTC Comparison

PTCT vs SMTC Comparison

Compare PTCT & SMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • SMTC
  • Stock Information
  • Founded
  • PTCT 1998
  • SMTC 1960
  • Country
  • PTCT United States
  • SMTC United States
  • Employees
  • PTCT N/A
  • SMTC N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • SMTC Semiconductors
  • Sector
  • PTCT Health Care
  • SMTC Technology
  • Exchange
  • PTCT Nasdaq
  • SMTC Nasdaq
  • Market Cap
  • PTCT 5.3B
  • SMTC 4.3B
  • IPO Year
  • PTCT 2013
  • SMTC N/A
  • Fundamental
  • Price
  • PTCT $75.70
  • SMTC $65.70
  • Analyst Decision
  • PTCT Buy
  • SMTC Strong Buy
  • Analyst Count
  • PTCT 17
  • SMTC 15
  • Target Price
  • PTCT $73.24
  • SMTC $64.87
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • SMTC 1.5M
  • Earning Date
  • PTCT 11-04-2025
  • SMTC 11-24-2025
  • Dividend Yield
  • PTCT N/A
  • SMTC N/A
  • EPS Growth
  • PTCT N/A
  • SMTC N/A
  • EPS
  • PTCT 8.94
  • SMTC 0.29
  • Revenue
  • PTCT $1,779,150,000.00
  • SMTC $996,476,000.00
  • Revenue This Year
  • PTCT $119.02
  • SMTC $15.91
  • Revenue Next Year
  • PTCT N/A
  • SMTC $9.77
  • P/E Ratio
  • PTCT $8.42
  • SMTC $227.09
  • Revenue Growth
  • PTCT 97.54
  • SMTC 22.22
  • 52 Week Low
  • PTCT $35.95
  • SMTC $24.05
  • 52 Week High
  • PTCT $76.80
  • SMTC $79.52
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 79.67
  • SMTC 44.74
  • Support Level
  • PTCT $69.23
  • SMTC $71.09
  • Resistance Level
  • PTCT $73.98
  • SMTC $75.50
  • Average True Range (ATR)
  • PTCT 2.67
  • SMTC 3.70
  • MACD
  • PTCT 0.40
  • SMTC -0.39
  • Stochastic Oscillator
  • PTCT 89.08
  • SMTC 23.71

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About SMTC Semtech Corporation

Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.

Share on Social Networks: